Clinical utility of ANCA tests for the dermatologist

Lawrence E. Gibson, Ulrich Specks, Henry Homburger

Research output: Contribution to journalReview articlepeer-review

23 Scopus citations

Abstract

In summary, cutaneous findings are not uncommon in WG or MPA. Unfortunately, cutaneous lesions may be nonspecific as these same patterns may also be seen in other systemic vasculitides or illnesses including classic polyarteritis nodosa or inflammatory bowel disease. Careful clinical examination and clinical pathologic correlation is required to confirm the diagnosis. Testing of antineutrophil cytoplasmic antibodies may play a significant role in the evaluation of patients suspected to have systemic vasculitis or another illness with presentations similar to WG. Only a positive c-ANCA IIF result together with a positive PR3-ANCA result obtained by EIA, and a positive p-ANCA IIF result together with a positive MPO-ANCA EIA result are sensitive and specific for WG and MPA. Repeat ANCA testing is warranted to follow the course of the disease in patients who have proven WG or MPA, as levels correlate loosely with disease activity and relapses in the absence of ANCA are rare. A patient with LCV or other cutaneous findings suggestive of WG with a positive C-ANCA/PR3-ANCA or p-ANCA/MPO-ANCA test result should be followed carefully for subsequent development of systemic disease manifestations even if there is no sign of internal organ involvement at the time of initial presentation.

Original languageEnglish (US)
Pages (from-to)859-869
Number of pages11
JournalInternational journal of dermatology
Volume42
Issue number11
DOIs
StatePublished - Nov 2003

ASJC Scopus subject areas

  • Dermatology

Fingerprint

Dive into the research topics of 'Clinical utility of ANCA tests for the dermatologist'. Together they form a unique fingerprint.

Cite this